J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...

Authorities accused Carlos Sacanell of trading on insider information to make illegal profits off of CVS Health's 2023 ...

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, Steve Nelson, a former UnitedHealthcare CEO.

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...